Apale FCM 50mg Injection

$74.15

1 Vial, 10 ml per vial

Active ingredient: Ferric Carboxymaltose (50mg/5ml)

Out of stock

Free worldwide shipping on all orders over $50

  • 30 days easy returns
  • Order yours before 2.30pm for same day dispatch
Guaranteed Safe Checkout

Placeholder
Apale FCM 50mg Injection
$74.15

Introduction

Apale FCM is a prescription medication that contains the active ingredient Ferric Carboxymaltose. It is available in injection form and is used to treat iron deficiency anemia in adults who cannot tolerate oral iron supplements or have not responded well to them. This medication is commonly prescribed by healthcare professionals to help restore iron levels in the body and improve symptoms associated with iron deficiency anemia.

Uses

Apale FCM is specifically indicated for the treatment of iron deficiency anemia in adult patients. Iron deficiency anemia occurs when the body does not have enough iron to produce adequate amounts of red blood cells, leading to fatigue, weakness, and other symptoms. This medication helps replenish iron stores in the body and promote the production of healthy red blood cells, thus alleviating the symptoms of iron deficiency anemia.

Dosage and Administration

Apale FCM is administered by a healthcare professional through an intravenous infusion. The dosage and frequency of administration will vary depending on the severity of the iron deficiency anemia and the individual patient’s response to treatment. Follow the healthcare professional’s instructions regarding the dosage and administration of this medication.

Mechanism of Action

The active ingredient in Apale FCM, Ferric Carboxymaltose, is a form of iron. Iron is an essential mineral that plays a crucial role in the production of red blood cells and the transportation of oxygen throughout the body. When administered intravenously, Ferric Carboxymaltose is rapidly absorbed by the body and taken up by the bone marrow, where it is used to produce new red blood cells. This helps restore iron levels in the body and improves the symptoms associated with iron deficiency anemia.

Side Effects

Common side effects may include nausea, vomiting, headache, dizziness, and injection site reactions such as redness or swelling. These side effects are usually mild and temporary.

However, be aware of and monitor for any serious side effects that may occur. These may include severe allergic reactions, chest pain, difficulty breathing, or swelling of the face, lips, tongue, or throat. If any of these serious side effects occur, seek immediate medical attention.

Drug Interactions

Apale FCM may interact with certain medications, so inform your healthcare professional about all the medications you are currently taking, including prescription, over-the-counter, and herbal products. Specifically, Apale FCM may interact with medications that affect the absorption or utilization of iron in the body, such as antacids, proton pump inhibitors, or calcium supplements. Your healthcare professional will be able to provide guidance on any potential drug interactions and adjust your treatment plan accordingly.

Precautions

Before using Apale FCM. Discuss your medical history and any existing conditions with your healthcare professional. This medication may not be suitable for individuals with certain conditions, such as iron overload disorders or active infections. Disclose any known allergies or sensitivities to medications.

In addition, Apale FCM should not be used during pregnancy unless specifically prescribed by a healthcare professional. Discuss the potential risks and benefits of using this medication during pregnancy or while breastfeeding.

Storage

Apale FCM should be stored in a cool, dry place, away from direct sunlight and heat. It should be kept out of the reach of children and pets. Follow the specific storage instructions provided by the manufacturer and to check the expiration date before using the medication.

Patient Tips

Here are a few tips to keep in mind when using Apale FCM:

  • Follow the dosage and administration instructions provided by your healthcare professional.
  • If you experience any side effects or have concerns about the medication, do not hesitate to contact your healthcare professional.
  • Keep all follow-up appointments with your healthcare professional to monitor your response to the medication and ensure the treatment is effective.
  • Inform your healthcare professional about any other medications or supplements you are taking to avoid potential drug interactions.
  • If you miss a dose, contact your healthcare professional for guidance on how to proceed.
  • Store the medication properly and check the expiration date before each use.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

  • Total iron-binding capacity (TIBC) and transferrin test (NHS UK) [Accessed 25 Jun. 2024] (online) Available at:
  • CosmoFer (Health Professionals SmPC) Available at:
  • Carbonyl iron (Drugs.com) [Accessed 24 Jun. 2024] (online) Available at:
  • carbonyl iron pediatric suspension (OTC) [Accessed 2 Jun. 2024] (online) Available at:
  • Basic Information about Mercury (Environmental Protection Agency) [Accessed 29 Jun. 2024] (online) Available at:
  • Xiao Z, Zhong W, Liu X. Recent developments in electrochemical investigations into iron carbonyl complexes relevant to the iron centres of hydrogenases. Dalton Trans. 2021 Dec 20;51(1):40-47. doi: 10.1039/d1dt02705k. [Accessed 22 Jun. 2024] Available at:

Additional information

Active ingredients

Strength

Ferric Carboxymaltose (50mg/5ml)

Dosage form

Injection

Indications

Iron deficiency anemia

Brand

Manufacturer

Manufacturer's location

C-401, Ganesh Meridian, Opp. Gujarat High Court, Sarkhej – Gandhinagar Hwy, Sola, Ahmedabad, Gujarat 380060

Reviews

There are no reviews yet.

Be the first to review “Apale FCM 50mg Injection”

Your email address will not be published. Required fields are marked *